Skip to main content

Table 3 Meta Regression for subgroups of relapse free patients

From: Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis

Variables Coef. Std. Err. z P > |z| [95% Conf. Interval]
Study type −0.7796787 0.1653799 −4.17 < 0.001 −1.103817 .920804
Duration of followup −0.208344 0.0071029 −2.93 0.003 −.0347557–.006913
AQP-4 positivity 0.0030413 0.0024175 1.26 0.208 −.0016968 .0077795
Site of injection 0.5235 0.1142147 4.58 < 0.001 .2996432 .7473567
_cons 0.6510876 0.2339978 2.78 0.005 −.1924603 1.109715